Rapid Hepatitis Tests

Both Hepatitis B and Hepatitis C are growing epidemics affecting people worldwide.  According to the World Health Organization (WHO) over 2 billion people are infected with the Hepatitis B virus (HBV), while some 180 million are infected with the Hepatitis C virus (HCV). 

The majority of people exposed to the Hepatitis B virus (HBV) will recover completely.  However, 10% of Hepatitis B infections become chronically infected. While many people with Hepatitis B are seemingly healthy, this is a serious disease that is associated with chronic liver disease, cirrhosis of the liver and liver cancer.  

HCV is considered a “hidden epidemic”, both because of the slow progress of the disease over the course of many years and the fact that many people remain unaware of their HCV infection.  Approximately 85% of HCV infected people will develop a chronic infection, with over 50% leading to cirrhosis of the liver and liver cancer.  HCV infections are the number one cause of liver transplant.

Traditional testing for both of these viruses is performed by experts, taking several days to a week to complete and requiring sophisticated equipment.  Simple and economical rapid testing can improve the delivery of results and outcomes of prevention programs with substantial time and cost savings.

MedMira markets its rapid HBV and HCV tests under the following brand names:

MiraWell HBV Rapid Test
MiraWell HCV Rapid Test